Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Scheltens

Showing results (101-110 of 266) with videos related to

Pageof 27
Sort By:
Biological Psychiatry|November 15, 1994
Cerebrospinal fluid acetylcholinesterase homospecific activity in patients with "probable Alzheimer's disease"C H Konings, P Scheltens, M A Kuiper, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 23, 2002
Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairmentP J Visser, F R J Verhey, P A M Hofman, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's diseaseM A Kuiper, G J van Kamp, P L Bergmans, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution?T Erkinjuntti, D Inzitari, L Pantoni, et al.
Neurobiology of Aging|March 21, 2007
Distortions in rest-activity rhythm in aging relate to white matter hyperintensitiesJ Oosterman, B van Harten, R Vogels, et al.
International Psychogeriatrics|July 21, 2009
The effect of anxiety and depression on decline of memory function in Alzheimer's diseaseE J M Bierman, H C Comijs, C Jonker, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug GuidelinesP Antuono, R Doody, S Gilman, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 10, 2000
L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patientsM A Kuiper, T Teerlink, J J Visser, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Cognitive slowing in multiple sclerosis is strongly associated with brain volume reductionR H C Lazeron, L M J de Sonneville, P Scheltens, et al.
Dementia and Geriatric Cognitive Disorders|December 18, 2008
Associations between patterns of EEG abnormalities and diagnosis in a large memory clinic cohortM Liedorp, W M van der Flier, E L J Hoogervorst, et al.
Pageof 27

Showing results (101-110 of 266) with videos related to

Sort By:
Pageof 27
Biological Psychiatry|November 15, 1994
Cerebrospinal fluid acetylcholinesterase homospecific activity in patients with "probable Alzheimer's disease"C H Konings, P Scheltens, M A Kuiper, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 23, 2002
Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairmentP J Visser, F R J Verhey, P A M Hofman, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's diseaseM A Kuiper, G J van Kamp, P L Bergmans, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution?T Erkinjuntti, D Inzitari, L Pantoni, et al.
Neurobiology of Aging|March 21, 2007
Distortions in rest-activity rhythm in aging relate to white matter hyperintensitiesJ Oosterman, B van Harten, R Vogels, et al.
International Psychogeriatrics|July 21, 2009
The effect of anxiety and depression on decline of memory function in Alzheimer's diseaseE J M Bierman, H C Comijs, C Jonker, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug GuidelinesP Antuono, R Doody, S Gilman, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 10, 2000
L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patientsM A Kuiper, T Teerlink, J J Visser, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Cognitive slowing in multiple sclerosis is strongly associated with brain volume reductionR H C Lazeron, L M J de Sonneville, P Scheltens, et al.
Dementia and Geriatric Cognitive Disorders|December 18, 2008
Associations between patterns of EEG abnormalities and diagnosis in a large memory clinic cohortM Liedorp, W M van der Flier, E L J Hoogervorst, et al.
Pageof 27